Michael Geldart has more than 30 years of experience in executive leadership, operations, health law, regulatory compliance, and corporate development. Most recently, Mr. Geldart was the Chief Operating Officer of BioTelemetry (Nasdaq: BEAT), the leading provider of cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. Previously, Mr. Geldart was the Chief Operating Officer of MedExpress, a leading multi-state urgent care provider and former portfolio company of Excellere Partners. Prior to that, Mr. Geldart was the Chief Operating Officer and EVP of Corporate Development of CCS Medical, a national provider of Medical and Pharmacy supplies for patients suffering from diabetes, respiratory, and other chronic conditions. Mr. Geldart began his career practicing healthcare law at Holland & Knight, LLP, a global law firm, and was promoted to Partner and served as the Co-Chair of the firm’s National Health Care Practice Group.
Mr. Geldart received a Juris Doctor degree from Stetson University College of Law and is a member of the Florida Bar. He received a Master of Science in Cybersecurity and a Bachelor of Arts in Chemistry from the University of South Florida.
Mr. Geldart is a member of the American Bar Association and serves on the Board of the St. Joseph’s Hospital Foundation in Denver Colorado.